The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

Oprah Winfrey revealed that earlier, she used to believe that “they ate better foods” and were able to stick to their diets ...

I never have used weight loss drugs to lose weight. I was blessed with a healthy pregnancy and gained very little during my pregnancy," Blanchard told PEOPLE ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

The latest health briefs reveal Novo Nordisk's promising obesity treatment and a $7.4 billion Purdue Pharma settlement over ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

Novo Nordisk shares were 9.5% higher after the pharmaceutical giant said an experimental weight-loss shot showed patients ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

Novo Nordisk shares jump close to 14% on promising trial results for amycretin, a once-weekly obesity drug, signaling fierce ...

The readout comes on the heels of CagriSema’s disappointing Phase III performance, where it missed Novo’s projection of 25% ...